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SUMMARY
The current study investigated the effects of supplementing rumen-protected choline (RPC) on
metabolic proﬁle, selected liver constituents and transcript levels of selected enzymes, transcription
factors and nuclear receptors involved in mammary lipid metabolism in dairy goats. Eight healthy
lactating goats were studied: four received no choline supplementation (CTR group) and four received
4 g RPC chloride/day (RPC group). The treatment was administered individually starting 4 weeks
before expected kidding and continuing for 4 weeks after parturition. In the ﬁrst month of lactation,
milk yield and composition were measured weekly. On days 7, 14, 21 and 27 of lactation, blood
samples were collected and analysed for glucose, β-hydroxybutyrate, non-esteriﬁed fatty acids and
cholesterol. On day 28 of lactation, samples of liver and mammary gland tissue were obtained. Liver
tissue was analysed for total lipid and DNA content; mammary tissue was analysed for transcripts of
lipoprotein lipase (LPL), fatty acid synthase (FAS), sterol regulatory binding proteins 1 and 2,
peroxisome proliferator-activated receptor γ and liver X receptor α. Milk yield was very similar in the
two groups, but RPC goats had lower (P<0·05) plasma β-hydroxybutyrate. The total lipid content of
liver was unaffected (P=0·890), but the total lipid/DNA ratio was lower (both P<0·05) in RPC than
CTR animals. Choline had no effect on the expression of the mammary gland transcripts involved in
lipid metabolism. The current plasma and liver data indicate that choline has a positive effect on liver
lipid metabolism, whereas it appears to have little effect on transcript levels in mammary gland of
various proteins involved in lipid metabolism. Nevertheless, the current results were obtained from a
limited number of animals, and choline requirement and function in lactating dairy ruminants deserve
further investigation.
INTRODUCTION
Choline is a vitamin-like compound with two known
functions: as choline per se and as a methyl donor,
although the two roles overlap. Choline per se is a
lipotropic agent playing a major role in lipid metab-
olism, particularly lipid transport, and is able to
prevent or correct excessive fat deposition in the liver.
This function is attributable to the presence of
choline in the phospolipids (phosphatidylcholine and
sphingomyelin) of lipoproteins. Impaired triglyceride
secretion in the form of very-low-density-proteins is
considered to be a major cause of fatty liver in choline
deﬁciency. As a methyl donor choline, like meth-
ionine, is an important source of labile methyl groups
for biosynthesis. Actually, the two principal methyl
donors in animal metabolism are betaine, a choline
metabolite, and S-adenosyl-L-methionine, a metab-
olite of methionine (Zeisel 1988; Pinotti et al. 2002).
For this reason, it has been suggested that choline,
betaine and methionine are closely interrelated metab-
olically. However, the requirement for choline per se
must be met as choline, and betaine can substitute for
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the methyl donor function of choline only, prob-
ably because betaine cannot be reduced to choline
(Zeisel 1988).
In adult ruminants, choline is extensively degraded
in the rumen so dietary choline contributes insignif-
icantly to the choline body pool. Methyl group
metabolism is therefore conservative with a relatively
low rate of methyl catabolism and an elevated rate of
de novo methyl group synthesis via the tetrahydrofo-
late system (Pinotti et al. 2002; Baldi & Pinotti 2006).
In dairy ruminants, the output of methylated com-
pounds in milk is high but the dietary availability of
choline is still low and precursors from the tetra-
hydrofolate pathway may be limiting, especially at the
onset of lactation (Baldi & Pinotti 2006). Based on
those considerations, the effects of rumen-protected
choline (RPC) supplementation to transition dairy
ruminants have been investigated in several studies
(Brüsemeister & Südekum 2006; Pinotti et al. 2008).
The latter study investigated the effects of RPC
administration on milk production and methyl group
metabolism during the periparturient period of dairy
goats, ﬁnding that RPC supplementation can increase
milk yield and milk fat concentration. The milk
production response to choline supplementation was
obtained without a detrimental effect on plasma
metabolites including folate and vitamin B12, indi-
cating that good methyl group status was maintained.
Further studies in dairy cows have also investigated
the effects of choline supplementation on hepatic
lipid metabolism (Piepenbrink & Overton 2003) and
lipidosis (Grummer 2006). The results obtained in
those studies indicated not only that hepatic fatty
acid metabolism and cow performance are responsive
to increasing the supply of choline (Piepenbrink &
Overton 2003), but also that choline supplementation
can reduce cellular lipid accumulation in the liver
(Grummer 2006). However, data on choline sup-
plementation and its effects on liver lipid accumu-
lation in dairy goats are lacking.
At the mammary gland level in dairy ruminants,
choline plays a major role in lipid metabolism,
particularly in lipid transport and milk fat secretion.
The long-chain fatty acids in milk are obtained from
the blood triglycerides of very low density lipoproteins
(VLDLs) which arise either from absorbed fat or
endogenously via mobilization of adipose fat stores.
When dietary or synthetic choline availability is
restricted, the rate of choline-containing phospholipid
synthesis decreases, affecting lipoprotein lipid trans-
port (Pinotti et al. 2002, 2003). Within the mammary
tissue many selected enzymes (e.g. lipoprotein lipase
(LPL)), transcription factors and nuclear receptors
that can be affected by choline availability are
involved in lipid uptake and milk fat secretion.
Furthermore, choline is actively secreted into mam-
malian milk. The major choline-containing com-
pounds in bovine milk are unesteriﬁed choline,
phosphatidylcholine and sphingomyelin (Pinotti et al.
2003). Kinsella (1973) reported that a bovine mam-
mary gland yielding 25 litres milk secretes 10±3 g
phospholipids per day, corresponding on average to
0·05 of the phospholipids of the mammary tissue.
The phospholipids of the membrane of the milk fat
globule constitute the major choline-containing com-
ponent of bovine milk (McPherson & Kitchen 1983).
The above data suggest that choline is an important
metabolite in lactating mammary tissue and that it is
used avidly when available (Kinsella 1973), mainly in
lipid metabolism. Thus, choline supplementation can
have positive effects on methyl group metabolism
(Emmanuel & Kennelly 1984; Baldi & Pinotti 2006;
Brüsemeister & Südekum 2006) and lipid trafﬁcking,
particularly lipid transport to extra-hepatic tissues
(Piepenbrink & Overton 2003; Baldi & Pinotti 2006;
Cooke et al. 2007), including the mammary gland.
However, the mechanisms of these effects have not yet
been clearly elucidated. In an attempt to shed light on
these mechanisms, dairy goats were studied during the
ﬁrst month of lactation, investigating the effects
of RPC administration on metabolic proﬁle, selected
liver constituents and transcript levels of selected
enzymes, transcription factors and nuclear receptors
involved in lipid metabolism in the mammary gland.
MATERIALS AND METHODS
Animals, treatment and diet
The animals were kept and cared for in accordance
with European Union guidelines (86/609/EEC) ap-
proved by the Italian Ministry of Health. The current
study was conducted as a parallel experiment to a
production trial in which 70 pregnant multiparous
Saanen goats were used (Pinotti et al. 2008). Due to
ethical reasons concerning the collection of tissues
samples, the experiment was performed using a lim-
ited number of animals. In order to have 0·90 power to
detect a signiﬁcant difference at P<0·05, four samples
per group were estimated as the minimum required.
Eight pregnant multiparous Saanen goats of similar
weight (mean 65±3·0 kg) and milk yield in the
previous lactation (mean of the ﬁrst month 2852±
360 g/day) at the Guidobono Cavalchini experimental
farm, University of Milan, were assigned to one of
two experimental groups: control group (CTR) with
no choline supplementation and RPC group given
4 g/day of choline chloride in rumen-protected form
(8 g of Sta-Chol Ascor Chimici, Forlì, Italy). The
quantity of choline was decided based on experience
with dairy cows (Pinotti et al. 2003) and metabolic
body weight at the beginning of the experiment.
The treatment was administered to each animal indi-
vidually before the morning feed to ensure complete
consumption, starting 4 weeks prior to expected
kidding and continuing for 4 weeks after parturition.
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During this period all goats were fed a basal diet
formulated to provide 8·37 and 10·0MJ of metaboliz-
able energy/kg dry matter (DM), 115 and 143 g
of crude proteins (CP)/kg DM, for pre-kidding and
lactation phase, respectively. The pre-partum and
lactation basal diets were formulated according to
the National Research Council (NRC 1981), and fed
as total mixed ration (Unifast SpA, Padova, Italy)
twice daily (06.30 and 18.30 h). Diet ingredients
and composition have been published elsewhere
(Pinotti et al. 2008). Before and after kidding, the
animals were housed in contiguous indoor stalls. Each
goat delivered two calfs, and after kidding the animals
were milked automatically twice a day. Post-kidding
dry matter intake (DMI) was assessed weekly for each
animal as the difference between feed DM offered and
feed DM refused.
Milk and plasma analysis
During the ﬁrst month of lactation, milk yield and
composition were determined weekly. On sampling
days, morning (06.30 h) and evening (18.30 h) milk
samples from each animal were collected and pooled
in proportion to the yield at each milking. The pooled
samples were treated with sodium azide and stored at
5 °C pending analysis for milk fat and milk protein
(Milkoscan, Foss Technology, Denmark). Jugular
vein blood samples were taken weekly, before the
ﬁrst meal of the day (06.00 h), and on days 7, 14, 21
and 28 post-partum. Blood samples were collected in
heparinized tubes (Venoject; Teruno Europe, Leuven,
Belgium) and centrifuged (14000 g for 15 min at
10 °C) to obtain plasma, which was stored at −20 °C
pending analysis. Non-esteriﬁed fatty acids (NEFA)
(acyl CoA synthetase, acyl CoA oxidase method –
NEFA Kit, Randox test, UK), cholesterol (Choles-
terol oxidase method, Diagnostic Cholesterol Kit,
Alfawassermann), and β-hydroxybutyrate (BHBA)
(β-hydroxybutyrate dehydrogenase method, RANBUT
Kit, Randox) were measured in all plasma samples
taken.
Biopsy preparation
On day 28 of lactation, 60 min before the liver and
mammary biopsy procedures, the goats were sampled
for blood (06·00 h) and treated with oxytocin (2 IU i.v,
Izossitocina IZO S.p.A, Brescia, Italy), and then
milked out. All goats were fed at the end of biopsy
procedure.
Biopsy and analysis of liver samples
Samples of liver parenchyma were obtained from each
animal using a blind percutaneous method and a 16G
Tru-Cut needle 115mm long (Urocore, H-S Medical
SpA. Pomezia, Rome, Italy). Sedatives were not given
so as not to disturb liver metabolism. The biopsy site
(11th intercostal space, c. 150 mm below the spine)
was shaved, surgically scrubbed and draped with
sterile drapes. Five ml of 20 mg/ml lidocaine solution
(Lidocaina 2% Fort Dodge, Fort Dodge Animal
Health; Aprilia, Latina, Italy) was administered and
a 40mm incision made. A Tru-Cut needle was intro-
duced in a cranio-ventral direction. About 100mg of
liver was collected per animal. The wound was sutured
subcutaneously with poliglecaprone 25 monoﬁlament
(2–0 USP) (Mnocryl, Ethicon, Johnson & Johnson
International, Stevenswulume, Belgium); the skin was
closed using individual sutures of polyamide mono-
ﬁlament (0 USP) (Daclon, S.M.I AG, Hünningen,
Belgium). The liver samples were frozen in liquid
nitrogen and stored at −80 °C pending analysis for
total lipid and DNA.
Lipids were extracted by the Folch method (Folch
et al. 1957). Brieﬂy, samples were thawed and total
lipid extracted in a suitable excess of chloroform:
methanol (2:1). After centrifugation, the lower phase
was evaporated under a nitrogen stream and weighed.
DNA was measured using the Burton (1956) method.
Brieﬂy, 100mg of tissue was homogenized with 7 ml
of cold 0·25 mM sucrose and 2mM MgCl2, and centri-
fuged at 1000 g for 10 min at 4 °C. The pellet was
resuspended in 0·2 ml of 9 g/l NaCl solution, washed
twice with 1 ml of 0·2 M perchloric acid (PCA)
solution and centrifuged at 2000 g for 10 min at 4 °C.
The pellet was re-suspended in 2 ml 0·5 N PCA at
75 °C for 15 min. After centrifugation at 2000 g for
10 min, 2 ml of diphenylamine reagent (containing 1 g
diphenylamine in 50 ml glacial acetic acid, 1 ml conc.
H2SO4 and 0·25 ml aqueous acetaldehyde (1:50 v/v))
was added to 1ml of supernatant. The mixture was
then incubated at 75 °C for 20 min. Calf thymus DNA
(200 μg/ml, Sigma) was used as standard. The blank
consisted of 1 ml of 0·5M PCA solution. Absorbance
at 600 nm was measured using a spectrophotometer
(Perkin Elmer). DNA tissue content has been used to
calculate total lipid/DNA ratio.
Biopsy and analysis of mammary samples
On day 28 of lactation, after liver biopsy mammary
tissue was biopsied from each animal. The animals
were sedated with 0·08 mg/kg i.v. xylazine chloro-
hydrate (Rompun, Bayer, Shawnee Mission, Kansas,
USA) and then placed in dorsal recumbency. Heart
rate and respiration were monitored continuously.
The biopsy site – 250mm distal to the basal part of
the right udder − was shaved, surgically scrubbed
and draped with sterile drapes. Five ml of 20 mg/ml
lidocaine solution (Lidocaina 2% Fort Dodge, Fort
Dodge Animal Health; Aprilia, Latina, Italy) was
injected at the biopsy site (line block). A 30–40mm
incision was made through the skin, avoiding visible
superﬁcial blood vessels. The incision was continued
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through subcutaneous tissue and fascia. Secretory
tissue was exposed and removed using dissecting
scissors. Approximately 1 g was removed, rinsed with
ml 9 g/l NaCl solution, and inspected to verify tissue
homogeneity. It was then frozen in liquid nitrogen
and stored at −80 °C pending analysis. Haemostasis
was achieved by ligation of blood vessels with catgut
3–0 USP (Assugut, Assut Europe S.p.A, Maliano
dei Marsi, L’Aquila, Italy). Connective tissue and
skin were closed using 3–0 USP poliglecaprone
25 (Mnocryl) and 2–0 USP polyamide (Daclon),
respectively. No other medication was given during
biopsy or afterwards.
Recovery from the liver and udder biopsies was
rapid and uneventful in all cases. In all animals, milk
yields returned to preoperative levels within 24 h.
The polyamide sutures were removed 13 d later from
both liver and mammary biopsy sites.
Transcript levels of LPL, fatty acid synthase (FAS),
sterol regulatory binding proteins 1 and 2 (SREBP-1
and SREBP-2), peroxisome proliferator-activated re-
ceptor γ (PPARγ) and liver X receptor α (LXRα) were
determined in mammary tissue. Total RNA was ex-
tracted using PeqGOLD Trifast (Peqlab, Germany)
according to the manufacturer’s instructions. RNA
quality was checked by electrophoresis on denaturat-
ing gel; quantity was estimated by measuring optical
density at 260 nm; integrity was checked by deter-
mining whether the OD260 nm/OD280 nm ratio >1·9.
One μg total RNA was used for the synthesis of ﬁrst
strand complementary DNA (cDNA) using 200 units
of reverse transcriptase (MMLV-RT, Promega,
Madison, WI, USA) and 100 pmol of random primers
(Invitrogen, Leek, The Netherlands) following the
manufacturers’ protocols.
PCR reactions and analyses were performed in
a Rotor-Gene 6000 (Corbett Research, Sydney,
Australia) using Sensimix No Ref DNA kits
(Quantacem, London, UK). Reaction tubes contained
20 ng of cDNA, 1 μl forward primer (5 pmol), 1 μl
reverse primer (5 pmol), 5 μl SensiMix (1 mMMgCl2),
0·2 μl 50×SYBR Green I and water to a ﬁnal volume
of 10 μl. Primer sequences for housekeeping (glyceral-
dehyde-3-phosphate dehydrogenase) and target genes
(LPL, FAS, SREBP-1, SREBP-2, PPARγ and LXRα)
were designed using published goat nucleic acid
sequences. Primer sequences are shown in Table 1.
Mixtures underwent the following real-time PCR
protocol: a denaturation programme (95 °C for 30 s)
and a three-phase ampliﬁcation/annealing programme
(95 °C for 10 s, 60 °C for 10 s, 72 °C for 15 s with a
single ﬂuorescence acquisition point) for 40 cycles.
The speciﬁcity and integrity of ampliﬁed PCR pro-
ducts were determined by melting curve analysis
and subsequent gel electrophoresis separation. Data
normalization was achieved using glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH) as an internal
control gene. This gene was selected as housekeeping
gene since its expression did not ﬂuctuate in goat
mammary tissues in response to the experimental
treatments (R. Bruckmaier, personal communica-
tion). Efﬁciency of ampliﬁcation for all determined
genes was determined by serial dilutions of pooled
samples and was found to be 1·9–2·0. Therefore, the
normalization could be performed as the difference
between the cycle threshold (Ct) values of GAPDH
and the target gene for each individual sample. Data
are presented as delta Ct values. mRNA expression
levels have been normalized to the housekeeping gene
GAPDH relative to total RNA and presented as
logarithm dualis.
Statistical analysis
Milk and plasma measurements were analysed using
the PROC MIXED procedure of SAS (1999). Liver
Table 1. Forward (for) and reverse (rev) primer sequences used for real time PCR ampliﬁcation of transcripts of
LPL, FAS, SREBP-1, SREBP-2, γPPARγ and αLXRα and the housekeeping gene GAPDH
Transcript Primer sequences (5′3′) Length (bp) Accession number
LPL for TTCAACCACAGCAGCAAGAC 207 DQ 370053.1
rev AAACTTGGCACATCCTGTC
FAS for ACAGCCTCTTCCTGTTTGACG 225 DQ 223929.1
rev CTCTGCACGATCAGCTCGAC
SREBP-1 for GACGGCCAGGTGAATCCAGA 207 NM 004599.2
rev CAGGACCATCTCTGCCCTCA
SREBP-2 for GACTGATGCCAAGATGCACA 140 XM 583656.3
rev CCCTTCAGGAGTTTGCTCTT
LXRα for CTGCGATTGAGGTGATGCTC 229 NM 001014861.1
rev CGGTCTGCAGAGAAGATGC
PPARγ for CTCCAAGAGTACCAAAGTGCAATC 198 NM 181024.2
rev CCGGAAGAAACCCTTGCATC
GAPDH for GTCTTCACTACCATGGAGAAGG 197 NM 001034034
rev TCATGGATGACCTTGGCCAG
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lipid, liver DNA, lipid/DNA ratio and udder tran-
scripts were analysed by the general linear model
procedure of SAS. The REPEATED statement was
used for variables measured over time (milk yield,
milk components and blood metabolites). The ran-
dom error term used for all mixed models was goat
within treatment group. Means were compared with
PDIFF option. Differences with P<0·05 were con-
sidered signiﬁcant.
RESULTS
Mean values of DMI, milk yield, milk composition
and plasma metabolites from the four determinations
(weeks 1−4) after kidding are shown in Table 2. Milk
yields were very similar in the CRT and RPC groups,
as were all the other milk variables measured over the
experimental period.
No choline effect was observed on plasma NEFA,
cholesterol and glucose. In contrast, plasma β-hydro-
xybutyrate was signiﬁcantly lower (P<0·05) in the
RPC group than in CRT group. With regard to liver
variables, it was found that total liver lipid content
was unaffected (P=0·890) by dietary treatment (45·35
and 46·03 mg/g wet tissue in RPC and CRT animals,
respectively), while total lipid/DNA ratio was signiﬁ-
cantly (P<0·05) lower (11·14 v. 15·87) in RPC than
CTR goats.
Transcript levels of various proteins and enzymes
involved in lipid metabolism in the mammary gland of
both CRT and RPC goats are shown in Table 3.
Choline supplementation had no effect on the ex-
pression of transcripts of LPL, FAS, SREBP-1,
SREBP-2, PPARγ and LXRα measured in mammary
gland tissues.
DISCUSSION
Previous studies carried out in dairy cows (Baldi &
Pinotti 2006; Brüsemeister & Südekum 2006) and
goats (Pinotti et al. 2008) have provided evidence that
higher choline availability can impact milk production
positively, when choline is administered in the rumen-
protected form. However, the current work showed
that milk yield and composition were similar in both
CRT and RPC group during the ﬁrst month of
lactation and that choline supplemented goats were
characterized only by lower (P<0·05) levels of plasma
β-hydroxybutyrate, compared to the control animals.
In a previous study on RPC-supplemented cows
(Pinotti et al. 2004), it was found that BHBA plasma
concentrations were reduced (not signiﬁcant) by 30%,
while Chung et al. (2005) found that RPC reduced
plasma NEFA concentrations by 11 and 23%, res-
pectively, in cows receiving doses of 25 and 50 g,
supporting a role of choline administration in improv-
ing lipid metabolism. Choline serves as methyl donor
in carnitine synthesis, which is essential for fatty acid
oxidation. At the beginning of lactation in dairy
ruminants, lipid mobilization leads to increased liver
uptake of NEFA with oxidation to carbon dioxide,
or esteriﬁcation to triglycerides. Less than optimal
beta-oxidation of fatty acids induces ketosis, while
triglyceride accumulation can lead to fatty liver.
Accordingly, liver lipid accumulation was studied in
the experimental goats. As a result, even though liver
lipid content was closely similar in the two groups, the
35% reduction in lipid/DNA ratio suggests reduced
hepatocellular lipid accumulation in RPC-treated
animals. Dairy cows receiving choline have also been
reported to have reduced hepatocellular lipid accu-
mulation (Grummer 2006; Cooke et al. 2007). These
ﬁndings are also consistent with the evidence that
RPC supplementation to dairy cows throughout the
periparturient period decreased liver accumulation of
lipids (stored as intracellular triglycerides) and in-
creased liver glycogen content (Piepenbrink & Overton
2003). Therefore, taken together, the current results
suggest that greater choline availability is useful for
optimizing liver lipid metabolism in dairy ruminants,
especially during the transition period.
Table 2. Mean values of DMI, milk yield, milk
composition and plasma metabolites on samples taken
weekly during weeks 1–4 of lactation in the CTR
(n=16) and RPC (n=16) groups
CTR RPC S.E.M.
DMI (kg/day) 2·10 2·18 0·059
Milk yield (g/day) 3855 3805 143·7
Milk fat (g/kg) 33·8 34·5 0·79
Milk protein (g/kg) 33·0 33·6 0·39
Plasma β-hydroxybutyrate
(mmol/l)
0·71 0·39 0·062
Plasma NEFA (mmol/l) 0·53 0·47 0·058
Plasma cholesterol (mmol/l) 2·45 2·83 0·159
Plasma glucose(mmol/l) 3·50 3·48 0·089
Table 3. mRNA expression levels of selected enzymes,
transcription factors and nuclear receptors involved in
lipid metabolism in the mammary gland according to
treatment group (mammary samples were collected on
day 28 of lactation)
Enzymes Units CTR RPC S.E.M.
FAS log2 12·8 12·4 0·53
LPL log2 12·8 11·2 0·80
SREBP-1 log2 6·2 6·0 0·42
SREBP-2 log2 8·3 8·2 0·45
PPARγ log2 6·2 6·0 0·38
LXRα log2 4·9 5·0 0·25
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A further aspect investigated in the present study
was the expression of several mammary gland tran-
scripts involved in lipid metabolism, which were
unaffected by choline supplementation. The effects of
nutrition on the expression of mammary lipogenic
genes in dairy ruminants have been investigated
mainly by feeding milk-fat depressing diets, charac-
terized by high levels of concentrates, or conjugated
linoleic acids (CLA) or other lipids (ﬁsh oil, vegetable
oils, full fat seeds, etc.). When speciﬁc CLA isomers
are fed, transcript levels of genes involved in fatty acid
uptake (LPL), de novo fatty acid synthesis (FAS) and
transcription factors (SREBP1) have been observed to
change (Bauman et al. 2008). Harvatine & Bauman
(2006) found reduced expression of SREBP1 and
SREBP activation protein during CLA-induced milk
fat depression in cows, suggesting that SREBP1 is a
central signalling pathway for the regulation of FAS
in the bovine mammary gland. In contrast, studies on
fat supplementation (vegetable oils and ﬁsh oils) for
goats indicate no effect or a tendency to decreased
mRNA levels of mammary LPL and FAS (see
Bernard et al. 2006 for a review), supporting the
observation that, although lipid supplementation
reduced milk fat synthesis in lactating goats
(and other dairy ruminants), the extent of milk fat
depression is less in goats than in dairy cows and sheep
(Lock et al. 2008). Little is known about the ex-
pression of SREBP2, PPARγ and LXRα transcripts
in the ruminant mammary gland. Although most
attention has focused on PPARs, little, if any, data are
available regarding the role of these transcription
factors in regulating milk fat synthesis in the mam-
mary gland (Bauman et al. 2008).
In the present study, the absence of signiﬁcant
effects on gene expression could be due to the dose
or to the type of supplementation of RPC. Thus,
while the current study supplied 4 g/day of choline
(2 g/kg DM), other studies used higher levels of sup-
plementation (for fat 36−112 g/kg DM) or more
potent nutritional factors (e.g. CLAs are potent inhi-
bitors of mammary gland fat synthesis). However,
in this context, a comparison between different
levels of milk yield and composition in response to
choline administration in goats merits further investi-
gation.
CONCLUSIONS
To conclude, the current plasma and liver data
indicate that choline pre-eminently acts on lipid meta-
bolism in early lactating goats. In contrast, choline
supplementation had no effect on transcript levels in
mammary gland of various proteins involved in lipid
metabolism. It is difﬁcult to establish if the absence
of response to the treatments in terms of milk
production and milk composition could be related to
the lack of effect on gene expression. Nevertheless,
the current results were obtained from a limited
number of animals, and choline requirement and
function in lactating dairy goats deserve further
investigation.
The authors wish to thank Professor Tom Fearn
(from University College of London) for his help in
reviewing the manuscript. This article has been
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